Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Influenza Vaccination in Immunocompromized Patients

This study has been completed.
Sponsor:
Collaborators:
Boehringer Ingelheim
Abbott
MSD Chibret Switzerland
Solvay Pharmaceuticals
Information provided by:
University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:
NCT00783380
First received: October 30, 2008
Last updated: October 31, 2008
Last verified: October 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2008
  Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)
No publications provided by University Hospital Inselspital, Berne

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):